StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex total assets

Total assets on the balance sheet at the end of each period.

Vaccinex's total assets was $2.60M at Dec 31, 2024. For fiscal 2024 it was $2.60M, down 28.5% from the year before. The highest annual figure on record is $22.03M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2024Dec 31, 2024$2.60M-28.5%
FY2023Dec 31, 2023$3.63M-54.5%
FY2022Dec 31, 2022$7.98M-19.0%
FY2021Dec 31, 2021$9.84M-15.9%
FY2020Dec 31, 2020$11.70M+154.2%
FY2019Dec 31, 2019$4.60M-79.1%
FY2018Dec 31, 2018$22.03M+295.1%
FY2017Dec 31, 2017$5.58M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$2.60M-28.5%
Q3 FY2024Sep 30, 2024$4.85M+89.8%
Q2 FY2024Jun 30, 2024$2.37M-23.3%
Q1 FY2024Mar 31, 2024$7.37M+50.5%
Q4 FY2023Dec 31, 2023$3.63M-54.5%
Q3 FY2023Sep 30, 2023$2.56M-70.3%
Q2 FY2023Jun 30, 2023$3.09M-75.5%
Q1 FY2023Mar 31, 2023$4.90M-73.0%
Q4 FY2022Dec 31, 2022$7.98M-19.0%
Q3 FY2022Sep 30, 2022$8.61M-43.3%
Q2 FY2022Jun 30, 2022$12.57M-47.2%
Q1 FY2022Mar 31, 2022$18.12M-40.9%
Q4 FY2021Dec 31, 2021$9.84M-15.9%
Q3 FY2021Sep 30, 2021$15.19M-18.9%
Q2 FY2021Jun 30, 2021$23.79M+667.6%
Q1 FY2021Mar 31, 2021$30.68M+528.6%
Q4 FY2020Dec 31, 2020$11.70M+154.2%
Q3 FY2020Sep 30, 2020$18.73M+73.2%
Q2 FY2020Jun 30, 2020$3.10M-56.5%
Q1 FY2020Mar 31, 2020$4.88M-63.3%
Q4 FY2019Dec 31, 2019$4.60M-79.1%
Q3 FY2019Sep 30, 2019$10.81M-63.8%
Q2 FY2019Jun 30, 2019$7.12M+51.0%
Q1 FY2019Mar 31, 2019$13.29M+138.5%
Q4 FY2018Dec 31, 2018$22.03M–
Q3 FY2018Sep 30, 2018$29.88M–
Q2 FY2018Jun 30, 2018$4.72M–
Q4 FY2017Dec 31, 2017$5.58M–

More Vaccinex figures

See a number that looks wrong?